Dyskinesia are a category of movement disorders characterized by involuntary muscle movements. They can be medication-induced, chronic, or non-motor in nature. Here is the latest research.

January 14, 2022

Movement disorders associated with neuronal antibodies: a data-driven approach.

Journal of Neurology
Andrea SturchioAlberto J Espay
January 14, 2022

Forefoot Injuries in Athletes: Integration of the Movement System.

International Journal of Sports Physical Therapy
Lindsay A CarrollRobRoy L Martin
January 12, 2022
Open Access

Impact of Motile Ciliopathies on Human Development and Clinical Consequences in the Newborn.

Rachael M Hyland, Steven L Brody
January 11, 2022
Open Access

A striatal plasticity that supports the long-term preservation of motor function in Parkinsonian mice.

BioRxiv : the Preprint Server for Biology
J. C. Brague, Rebecca P Seal
January 10, 2022

Routine Exposure Versus Non-Exposure of Recurrent Laryngeal Nerve during Thyroid Surgery: Our Experience of 300 Cases.

Mymensingh Medical Journal : MMJ
S S BiswasS F Razib
January 11, 2022

Orobuccolingual Dyskinesia: A Rare Complication Following Gas Geyser Encephalopathy.

Annals of Indian Academy of Neurology
Kartik J KachhadiyaPettarusp M Wadia
January 11, 2022

ADCY5-Related Dyskinesia: A Genetic Cause of Early-Onset Chorea-Report of Two Cases and a Novel Mutation.

Annals of Indian Academy of Neurology
Hansashree PadmanabhaMathuranath Pavagada
January 11, 2022

Single-Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa-Carbidopa Intestinal Gel.

Movement Disorders Clinical Practice
Vili ViljaharjuEero Pekkonen
January 11, 2022

Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson's disease: A prospective study of 22 patients.

Clinical Parkinsonism & Related Disorders
Gustavo Fernández-PajarínAlfonso Castro
January 11, 2022

Evaluation of the Surgical Management of Achalasia in Children and Young Adults.

The Journal of Surgical Research
Carly WestermannAlejandro V Garcia
January 9, 2022

Proline-rich transmembrane protein 2 specifically binds to GluA1 but has no effect on AMPA receptor-mediated synaptic transmission.

Journal of Clinical Laboratory Analysis
Hao-Yang FengZhengfeng Xu
January 8, 2022

Neurologists' Attitudes Toward Use and Timing of Deep Brain Stimulation.

Neurology. Clinical Practice
Laura Yenisa CabreraHarini Sarva
January 8, 2022

Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics.

Neurology. Clinical Practice
Philippe A SallesAlberto J Espay
January 7, 2022

Awake craniotomy for removal of gliomas in eloquent areas: an analysis of 21 cases.

Brain Research Bulletin
Xi ChenZhanxiang Wang
January 6, 2022
Case Report

Belly Dancer Dyskinesia During Pregnancy: Case Report from Harar, Eastern Ethiopia.

International Medical Case Reports Journal
Tadesse Gure

Sign up to follow this feed and discover related papers.

Related Feeds


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.


Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cervical Dystonia

Cervical dystonia, or spasmodic torticollis, is a neurological disorder in which involuntary muscle contractions in the neck cause abnormal head and neck movements. Current treatment options include botulinum toxin injections, oral medications, and surgery. Find the latest research on cervical dystonia here.

© 2022 Meta ULC. All rights reserved